Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2008

Open Access 01-12-2008 | Research

EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)

Authors: Susan Grandy, Kathleen M Fox

Published in: Health and Quality of Life Outcomes | Issue 1/2008

Login to get access

Abstract

Background

The EQ-5D was used to compare burden experienced by respondents with diabetes and those at risk for diabetes.

Methods

A survey including the EQ-5D was mailed to individuals with self-reported diabetes, as well as those without diabetes but with the following risk factors (RFs): (1) abdominal obesity, (2) body mass index ≥ 28 kg/m2, (3) dyslipidemia, (4) hypertension, and (5) cardiovascular disease. Non-diabetes respondents were combined into 0–2 RFs and 3–5 RFs. Mean EQ-5D scores were compared across groups using analysis of variance. Multivariable linear regression modeling identified factors affecting respondents' EQ-5D scores.

Results

Complete responses were available from >75% of each cohort. Mean EQ-5D index scores were significantly lower for respondents with type 2 diabetes and 3–5 RFs (0.778 and 0.792, respectively) than for those with 0–2 RFs (0.870, p < 0.001 for each); score for respondents with type 2 diabetes was also significantly lower than for those with 3–5 RFs (p < 0.001). Similar patterns were seen for visual analog scale (VAS). For both VAS and index scores, after adjusting for other characteristics, respondents reported decreasing EQ-5D scores as status moved from low to high risk (-6.49 for VAS score and -0.045 for index score) to a diagnosis of type 2 diabetes (-9.75 for VAS score and -0.054 for index score; p < 0.001 vs. 0–2 RFs for all).

Conclusion

High-risk and type 2 diabetes groups had similar EQ-5D scores, and both were substantially lower than in low-risk respondents.
Appendix
Available only for authorised users
Literature
1.
go back to reference Centers for Disease Control and Prevention: National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2005. Centers for Disease Control and Prevention: National diabetes fact sheet: general information and national estimates on diabetes in the United States, 2005. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2005.
3.
go back to reference Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitee. Circulation 2006, 113: e85-e151. 10.1161/CIRCULATIONAHA.105.171600CrossRefPubMed Thom T, Haase N, Rosamond W, Howard VJ, Rumsfeld J, Manolio T, Zheng ZJ, Flegal K, O'Donnell C, Kittner S, Lloyd-Jones D, Goff DC Jr, Hong Y, Adams R, Friday G, Furie K, Gorelick P, Kissela B, Marler J, Meigs J, Roger V, Sidney S, Sorlie P, Steinberger J, Wasserthiel-Smoller S, Wilson M, Wolf P, American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics – 2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommitee. Circulation 2006, 113: e85-e151. 10.1161/CIRCULATIONAHA.105.171600CrossRefPubMed
4.
go back to reference Luscombe FA: Health-related quality of life measurement in type 2 diabetes. Value Health 2000, 3(Suppl 1):15–28. 10.1046/j.1524-4733.2000.36032.xCrossRefPubMed Luscombe FA: Health-related quality of life measurement in type 2 diabetes. Value Health 2000, 3(Suppl 1):15–28. 10.1046/j.1524-4733.2000.36032.xCrossRefPubMed
5.
go back to reference Garratt AM, Schmidt L, Fitzpatrick R: Patient-assisted health outcome measures for diabetes: A structured review. Diabet Med 2002, 19: 1–11. 10.1046/j.1464-5491.2002.00650.xCrossRefPubMed Garratt AM, Schmidt L, Fitzpatrick R: Patient-assisted health outcome measures for diabetes: A structured review. Diabet Med 2002, 19: 1–11. 10.1046/j.1464-5491.2002.00650.xCrossRefPubMed
6.
go back to reference Watkins K, Connell CM: Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 2004, 22: 1109–1126. 10.2165/00019053-200422170-00002CrossRefPubMed Watkins K, Connell CM: Measurement of health-related QOL in diabetes mellitus. Pharmacoeconomics 2004, 22: 1109–1126. 10.2165/00019053-200422170-00002CrossRefPubMed
7.
go back to reference Centers for Disease Control and Prevention: Self-rated fair or poor health among adults with diabetes – United States, 1996–2005. MMWR 2006, 55: 1224–1227. Centers for Disease Control and Prevention: Self-rated fair or poor health among adults with diabetes – United States, 1996–2005. MMWR 2006, 55: 1224–1227.
8.
go back to reference Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG: A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997, 20: 299–305. 10.2337/diacare.20.3.299CrossRefPubMed Anderson RM, Fitzgerald JT, Wisdom K, Davis WK, Hiss RG: A comparison of global versus disease-specific quality-of-life measures in patients with NIDDM. Diabetes Care 1997, 20: 299–305. 10.2337/diacare.20.3.299CrossRefPubMed
9.
go back to reference Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33: 337–343.CrossRefPubMed Rabin R, de Charro F: EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001, 33: 337–343.CrossRefPubMed
10.
go back to reference Bays HE, Chapman RH, Grandy S, the SHIELD Investigators' Group: The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007, 61: 737–747. 10.1111/j.1742-1241.2007.01336.xPubMedCentralCrossRefPubMed Bays HE, Chapman RH, Grandy S, the SHIELD Investigators' Group: The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys. Int J Clin Pract 2007, 61: 737–747. 10.1111/j.1742-1241.2007.01336.xPubMedCentralCrossRefPubMed
11.
go back to reference American Diabetes Association: Standards of Medical Care in Diabetes – 2007. Diabetes Care 2007, 30(Suppl 1):S4-S41. 10.2337/dc07-S004CrossRef American Diabetes Association: Standards of Medical Care in Diabetes – 2007. Diabetes Care 2007, 30(Suppl 1):S4-S41. 10.2337/dc07-S004CrossRef
13.
go back to reference EuroQoL Group: EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990, 16: 199–208. 10.1016/0168-8510(90)90421-9CrossRef EuroQoL Group: EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990, 16: 199–208. 10.1016/0168-8510(90)90421-9CrossRef
14.
go back to reference Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Med Care 2005, 43: 203–220. 10.1097/00005650-200503000-00003CrossRefPubMed Shaw JW, Johnson JA, Coons SJ: US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Med Care 2005, 43: 203–220. 10.1097/00005650-200503000-00003CrossRefPubMed
15.
go back to reference Sapin C, Fantino B, Nowicki M, Kind P: Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes 2004, 2: 20. 10.1186/1477-7525-2-20PubMedCentralCrossRefPubMed Sapin C, Fantino B, Nowicki M, Kind P: Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder. Health and Quality of Life Outcomes 2004, 2: 20. 10.1186/1477-7525-2-20PubMedCentralCrossRefPubMed
16.
go back to reference Kind P, Koltowska-Haggstrom M: Incorporating social preferences in the measurement of QoL outcomes in growth hormone deficiency (GHD) in adults. Endocrine Abstracts 2004, 7: P147. Kind P, Koltowska-Haggstrom M: Incorporating social preferences in the measurement of QoL outcomes in growth hormone deficiency (GHD) in adults. Endocrine Abstracts 2004, 7: P147.
17.
go back to reference Hart HE, Redekop WK, Bilo HJG, Meyboom B, Berg M: Health related quality of life in patients with type I diabetes mellitus: generic and disease-specific measurement. Indian J Med Res 2007, 125: 203–216.PubMed Hart HE, Redekop WK, Bilo HJG, Meyboom B, Berg M: Health related quality of life in patients with type I diabetes mellitus: generic and disease-specific measurement. Indian J Med Res 2007, 125: 203–216.PubMed
18.
go back to reference Cavrini G, Pacelli B, Pandolfi P, Collina N, Mezzetti F, Pesci P, Perlangeli V: A proposal for modeling an EQ-5D index by ordered regression model. University of Bologna, Italy 2004. Cavrini G, Pacelli B, Pandolfi P, Collina N, Mezzetti F, Pesci P, Perlangeli V: A proposal for modeling an EQ-5D index by ordered regression model. University of Bologna, Italy 2004.
19.
go back to reference Sitoh YY, Lau TC, Zochling J, Schwarz J, Chen JS, March LM, Cumming RG, Lord SR, Sambrook PN, Cameron ID: Determinants of health-related quality of life in institutionalized older persons in northern Sydney. Internal Med J 2005, 35: 131–134. 10.1111/j.1445-5994.2004.00742.xCrossRef Sitoh YY, Lau TC, Zochling J, Schwarz J, Chen JS, March LM, Cumming RG, Lord SR, Sambrook PN, Cameron ID: Determinants of health-related quality of life in institutionalized older persons in northern Sydney. Internal Med J 2005, 35: 131–134. 10.1111/j.1445-5994.2004.00742.xCrossRef
20.
go back to reference Hanninen J, Takala J, Keinanen-Kiukaanniemi S: Quality of life in NIDDM patients assessed with the SF-20 questionnaire. Diabetes Res Clin Pract 1998, 42: 17–27. 10.1016/S0168-8227(98)00085-0CrossRefPubMed Hanninen J, Takala J, Keinanen-Kiukaanniemi S: Quality of life in NIDDM patients assessed with the SF-20 questionnaire. Diabetes Res Clin Pract 1998, 42: 17–27. 10.1016/S0168-8227(98)00085-0CrossRefPubMed
21.
go back to reference Schlotz W, Ambery P, Syddall HE, Crozier SR, Sayer AA, Cooper C, Phillips DI, Hertfordshire Cohort Study Group: Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 2007, 16: 429–436. 10.1007/s11136-006-9129-5CrossRefPubMed Schlotz W, Ambery P, Syddall HE, Crozier SR, Sayer AA, Cooper C, Phillips DI, Hertfordshire Cohort Study Group: Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 2007, 16: 429–436. 10.1007/s11136-006-9129-5CrossRefPubMed
22.
go back to reference Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T: A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res 2007, 26: 179–189. 10.1007/s11136-006-0031-yCrossRef Ribu L, Hanestad BR, Moum T, Birkeland K, Rustoen T: A comparison of the health-related quality of life in patients with diabetic foot ulcers, with a diabetes group and a nondiabetes group from the general population. Qual Life Res 2007, 26: 179–189. 10.1007/s11136-006-0031-yCrossRef
23.
go back to reference Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO: Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity 2007, 15: 511–521.CrossRefPubMed Sullivan PW, Ghushchyan V, Wyatt HR, Wu EQ, Hill JO: Impact of cardiometabolic risk factor clusters on health-related quality of life in the U.S. Obesity 2007, 15: 511–521.CrossRefPubMed
24.
go back to reference Sullivan PW, Lawrence WF Jr, Ghushchyan V: A national catalogue of preference-based scores for chronic conditions in the U.S. Med Care 2005, 43: 736–749. 10.1097/01.mlr.0000172050.67085.4fCrossRefPubMed Sullivan PW, Lawrence WF Jr, Ghushchyan V: A national catalogue of preference-based scores for chronic conditions in the U.S. Med Care 2005, 43: 736–749. 10.1097/01.mlr.0000172050.67085.4fCrossRefPubMed
25.
go back to reference Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A: Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EUROQOL (EQ-5D). Brit J Rheumatol 1997, 36: 551–559. 10.1093/rheumatology/36.5.551CrossRef Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A: Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EUROQOL (EQ-5D). Brit J Rheumatol 1997, 36: 551–559. 10.1093/rheumatology/36.5.551CrossRef
26.
go back to reference Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J: A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. J Rheumatol 2003, 30: 2268–2274.PubMed Luo N, Chew LH, Fong KY, Koh DR, Ng SC, Yoon KH, Vasoo S, Li SC, Thumboo J: A comparison of the EuroQol-5D and the Health Utilities Index mark 3 in patients with rheumatic disease. J Rheumatol 2003, 30: 2268–2274.PubMed
27.
go back to reference Pickard AS, Johnson JA, Feeny DH: Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 2005, 14: 207–219. 10.1007/s11136-004-3928-3CrossRefPubMed Pickard AS, Johnson JA, Feeny DH: Responsiveness of generic health-related quality of life measures in stroke. Qual Life Res 2005, 14: 207–219. 10.1007/s11136-004-3928-3CrossRefPubMed
28.
go back to reference Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, Scott-Lennox J, Feinberg J: Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002, 11: 273–282. 10.1023/A:1015240103565CrossRefPubMed Wu AW, Jacobson KL, Frick KD, Clark R, Revicki DA, Freedberg KA, Scott-Lennox J, Feinberg J: Validity and responsiveness of the euroqol as a measure of health-related quality of life in people enrolled in an AIDS clinical trial. Qual Life Res 2002, 11: 273–282. 10.1023/A:1015240103565CrossRefPubMed
29.
go back to reference Wee HL, Machlin D, Loke WC, Li SC, Cheung YB, Luo N, Feeny D, Fong KY, Thumboo J: Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value Health 2007, 10: 256–265. 10.1111/j.1524-4733.2007.00174.xCrossRefPubMed Wee HL, Machlin D, Loke WC, Li SC, Cheung YB, Luo N, Feeny D, Fong KY, Thumboo J: Assessing differences in utility scores: a comparison of four widely used preference-based instruments. Value Health 2007, 10: 256–265. 10.1111/j.1524-4733.2007.00174.xCrossRefPubMed
Metadata
Title
EQ-5D visual analog scale and utility index values in individuals with diabetes and at risk for diabetes: Findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD)
Authors
Susan Grandy
Kathleen M Fox
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2008
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-6-18

Other articles of this Issue 1/2008

Health and Quality of Life Outcomes 1/2008 Go to the issue